The 10-day moving average for FMS crossed bullishly above the 50-day moving average on November 13, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on November 08, 2024. You may want to consider a long position or call options on FMS as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for FMS just turned positive on November 06, 2024. Looking at past instances where FMS's MACD turned positive, the stock continued to rise in of 49 cases over the following month. The odds of a continued upward trend are .
FMS moved above its 50-day moving average on November 06, 2024 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where FMS advanced for three days, in of 319 cases, the price rose further within the following month. The odds of a continued upward trend are .
FMS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The RSI Indicator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 6 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where FMS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.762) is normal, around the industry mean (4.525). P/E Ratio (20.797) is within average values for comparable stocks, (71.137). FMS's Projected Growth (PEG Ratio) (0.452) is slightly lower than the industry average of (1.595). Dividend Yield (0.030) settles around the average of (0.026) among similar stocks. P/S Ratio (0.533) is also within normal values, averaging (20.576).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FMS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FMS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.
a manufacturer of renal and dialysis products
Industry MedicalNursingServices